FGF9 was first identified from the secretions of human glioma MCF-G1 cells, and found to promote NIH-3T3 cell line malignant transformation, suggesting that FGF9 may be a tumor-promoting factor (31). The gene discussed is FGF9; the disease is central nervous system cancer.